Treatment of polymyositis and dermatomyositis.
Dalakas
M
M
National Institutes of Health, Bethesda, Maryland.
D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D003882:Dermatomyositis / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009135:Muscular Diseases / Q000139:chemically induced; D009220:Myositis / Q000188:drug therapy*; D011241:Prednisone / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D011241:Prednisone